{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T05:01:15Z","timestamp":1784350875885,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.xphs.2024.05.008","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T10:07:04Z","timestamp":1715940424000},"page":"2065-2071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Understanding the Effects of Site-Specific Light Chain Conjugation on Antibody Structure Using Hydrogen Exchange-Mass Spectrometry (HX-MS)"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0122-3861","authenticated-orcid":false,"given":"Sachini P.","family":"Karunaratne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehab M.","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4862-9380","authenticated-orcid":false,"given":"Brittney J.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3032-1211","authenticated-orcid":false,"given":"David D.","family":"Weis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.xphs.2024.05.008_bib0001","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20150089","article-title":"Antibody\u2013drug conjugates as novel anti-cancer chemotherapeutics","volume":"35","author":"Peters","year":"2015","journal-title":"Biosci Rep"},{"issue":"1","key":"10.1016\/j.xphs.2024.05.008_bib0002","article-title":"Antibody drug conjugate: the \u201cbiological missile\u201d for targeted cancer therapy","volume":"7","author":"Fu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"10.1016\/j.xphs.2024.05.008_bib0003","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrc2394","article-title":"Paul Ehrlich's magic bullet concept: 100 years of progress","volume":"8","author":"Strebhardt","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.xphs.2024.05.008_bib0004","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.xphs.2019.05.031","article-title":"Considerations for the design of antibody-based therapeutics","volume":"109","author":"Goulet","year":"2020","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2024.05.008_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102395","article-title":"Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives","volume":"106","author":"Nicol\u00f2","year":"2022","journal-title":"Cancer Treat Rev"},{"issue":"9","key":"10.1016\/j.xphs.2024.05.008_bib0006","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/nbt1141","article-title":"Arming antibodies: prospects and challenges for immunoconjugates","volume":"23","author":"Wu","year":"2005","journal-title":"Nat Biotechnol"},{"issue":"19","key":"10.1016\/j.xphs.2024.05.008_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26195847","article-title":"An insight into FDA approved antibody-drug conjugates for cancer therapy","volume":"26","author":"Tong","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.xphs.2024.05.008_bib0008","article-title":"Antibody-drug conjugates in lung cancer: dawn of a new era?","volume":"7","author":"Coleman","year":"2023","journal-title":"NPJ Precis Oncol"},{"issue":"2","key":"10.1016\/j.xphs.2024.05.008_bib0009","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4161\/mabs.3.2.14960","article-title":"Analytical methods for physicochemical characterization of antibody drug conjugates","volume":"3","author":"Wakankar","year":"2014","journal-title":"mAbs"},{"issue":"7","key":"10.1016\/j.xphs.2024.05.008_bib0010","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1007\/s11095-013-1274-2","article-title":"Assessment of physical stability of an antibody drug conjugate by higher order structure analysis: impact of thiol- maleimide chemistry","volume":"31","author":"Guo","year":"2014","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.xphs.2024.05.008_bib0011","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1021\/acs.bioconjchem.5b00603","article-title":"Characterization and higher-order structure assessment of an interchain cysteine-based ADC: impact of drug loading and distribution on the mechanism of aggregation","volume":"27","author":"Guo","year":"2016","journal-title":"Bioconjug Chem"},{"issue":"9","key":"10.1016\/j.xphs.2024.05.008_bib0012","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1021\/bc900434c","article-title":"Physicochemical stability of the antibody\u2212drug conjugate trastuzumab-DM1: changes due to modification and conjugation processes","volume":"21","author":"Wakankar","year":"2010","journal-title":"Bioconjug Chem"},{"issue":"2","key":"10.1016\/j.xphs.2024.05.008_bib0013","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1039\/D0CS00310G","article-title":"Site-selective modification strategies in antibody\u2013drug conjugates","volume":"50","author":"Walsh","year":"2021","journal-title":"Chem Soc Rev"},{"issue":"2","key":"10.1016\/j.xphs.2024.05.008_bib0014","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1021\/bc5004982","article-title":"Site-specific antibody\u2013drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug development","volume":"26","author":"Agarwal","year":"2015","journal-title":"Bioconjug Chem"},{"issue":"5","key":"10.1016\/j.xphs.2024.05.008_bib0015","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.xphs.2020.01.029","article-title":"Effect of linker-drug properties and conjugation site on the physical stability of ADCs","volume":"109","author":"Mills","year":"2020","journal-title":"J Pharm Sci"},{"issue":"12","key":"10.1016\/j.xphs.2024.05.008_bib0016","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1021\/jacs.1c07675","article-title":"Single mutation on trastuzumab modulates the stability of antibody\u2013drug conjugates built using acetal-based linkers and thiol-maleimide chemistry","volume":"144","author":"Ferhati","year":"2022","journal-title":"J Am Chem Soc"},{"issue":"1","key":"10.1016\/j.xphs.2024.05.008_bib0017","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1039\/C2SC21107F","article-title":"Spacer length shapes drug release and therapeutic efficacy of traceless disulfide-linked ADCs targeting the tumor neovasculature","volume":"4","author":"Steiner","year":"2013","journal-title":"Chem Sci"},{"issue":"6","key":"10.1016\/j.xphs.2024.05.008_bib0018","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1158\/0008-5472.CAN-08-2250","article-title":"Antibody-drug conjugates for the treatment of non\u2013Hodgkin's lymphoma: target and linker-drug selection","volume":"69","author":"Polson","year":"2009","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.xphs.2024.05.008_bib0019","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.2108","article-title":"Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates","volume":"30","author":"Shen","year":"2012","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.xphs.2024.05.008_bib0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4161\/mabs.27022","article-title":"Site-specific antibody drug conjugates for cancer therapy","volume":"6","author":"Panowski","year":"2013","journal-title":"mAbs"},{"issue":"7","key":"10.1016\/j.xphs.2024.05.008_bib0021","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1021\/ac504804m","article-title":"Mapping monoclonal antibody structure by 2D 13C NMR at natural abundance","volume":"87","author":"Arbogast","year":"2015","journal-title":"Anal Chem"},{"issue":"21","key":"10.1016\/j.xphs.2024.05.008_bib0022","doi-asserted-by":"crossref","first-page":"11839","DOI":"10.1021\/acs.analchem.7b03571","article-title":"Multivariate analysis of two-dimensional 1H, 13C methyl NMR spectra of monoclonal antibody therapeutics to facilitate assessment of higher order structure","volume":"89","author":"Arbogast","year":"2017","journal-title":"Anal Chem"},{"issue":"7","key":"10.1016\/j.xphs.2024.05.008_bib0023","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nrd3746","article-title":"Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars","volume":"11","author":"Berkowitz","year":"2012","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"10.1016\/j.xphs.2024.05.008_bib0024","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s13361-018-1966-2","article-title":"Conformational assessment of Adnectin and Adnectin-drug conjugate by hydrogen\/deuterium exchange mass spectrometry","volume":"29","author":"Huang","year":"2018","journal-title":"J Am Soc Mass Spectrom"},{"issue":"1","key":"10.1016\/j.xphs.2024.05.008_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010046","article-title":"Role of NMR in high ordered structure characterization of monoclonal antibodies","volume":"22","author":"Tokunaga","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xphs.2024.05.008_bib0026","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.aca.2016.08.006","article-title":"Hydrogen deuterium exchange mass spectrometry in biopharmaceutical discovery and development \u2013 a review","volume":"940","author":"Deng","year":"2016","journal-title":"Anal Chim Acta"},{"issue":"2","key":"10.1016\/j.xphs.2024.05.008_bib0027","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/jps.24224","article-title":"Hydrogen-deuterium exchange mass spectrometry as an emerging analytical tool for stabilization and formulation development of therapeutic monoclonal antibodies","volume":"104","author":"Majumdar","year":"2015","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2024.05.008_bib0028","series-title":"State-of-the-Art and Emerging Technologies for Therapeutic Monoclonal Antibody Characterization Volume 3. Defining the Next Generation of Analytical and Biophysical Techniques","first-page":"17","article-title":"Emerging technologies to assess the higher order structure of monoclonal antibodies","author":"Marino","year":"2015"},{"issue":"2","key":"10.1016\/j.xphs.2024.05.008_bib0029","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejps.2009.06.001","article-title":"Structural properties of monoclonal antibody aggregates induced by freeze\u2013thawing and thermal stress","volume":"38","author":"Hawe","year":"2009","journal-title":"Eur J Pharmaceut Sci"},{"issue":"5","key":"10.1016\/j.xphs.2024.05.008_bib0030","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1021\/acs.molpharmaceut.6b00995","article-title":"Efficient preparation of site-specific antibody\u2013drug conjugates using cysteine insertion","volume":"14","author":"Dimasi","year":"2017","journal-title":"Mol Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2024.05.008_bib0031","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jim.2007.12.011","article-title":"Rapid identification of reactive cysteine residues for site-specific labeling of antibody-fabs","volume":"332","author":"Junutula","year":"2008","journal-title":"J Immunol Methods"},{"issue":"8","key":"10.1016\/j.xphs.2024.05.008_bib0032","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nbt.1480","article-title":"Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index","volume":"26","author":"Junutula","year":"2008","journal-title":"Nat Biotechnol"},{"issue":"5","key":"10.1016\/j.xphs.2024.05.008_bib0033","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1021\/ac404003q","article-title":"Conformation and dynamics of interchain cysteine-linked antibody-drug conjugates as revealed by hydrogen\/deuterium exchange mass spectrometry","volume":"86","author":"Pan","year":"2014","journal-title":"Anal Chem"},{"issue":"11","key":"10.1016\/j.xphs.2024.05.008_bib0034","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1021\/acs.analchem.5b00764","article-title":"Antibody structural integrity of site-specific antibody-drug conjugates investigated by hydrogen\/deuterium exchange mass spectrometry","volume":"87","author":"Pan","year":"2015","journal-title":"Anal Chem"},{"issue":"6","key":"10.1016\/j.xphs.2024.05.008_bib0035","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.xphs.2021.03.006","article-title":"Stability of antibody drug conjugate formulations evaluated using solid-state hydrogen-deuterium exchange mass spectrometry","volume":"110","author":"Cho","year":"2021","journal-title":"J Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2024.05.008_bib0036","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/jps.23543","article-title":"Correlating excipient effects on conformational and storage stability of an IgG1 monoclonal antibody with local dynamics as measured by hydrogen\/deuterium-exchange mass spectrometry","volume":"102","author":"Manikwar","year":"2013","journal-title":"J Pharm Sci"},{"issue":"12","key":"10.1016\/j.xphs.2024.05.008_bib0037","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1007\/s13361-012-0485-9","article-title":"Minimizing carry-over in an online pepsin digestion system used for the H\/D exchange mass spectrometric analysis of an IgG1 monoclonal antibody","volume":"23","author":"Majumdar","year":"2012","journal-title":"J Am Soc Mass Spectrom"},{"issue":"1","key":"10.1016\/j.xphs.2024.05.008_bib0038","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1021\/j100830a521","article-title":"Use of glass electrodes to measure acidities in deuterium oxide","volume":"64","author":"Glasoe","year":"2002","journal-title":"J Phys Chem"},{"issue":"6","key":"10.1016\/j.xphs.2024.05.008_bib0039","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.xphs.2021.02.027","article-title":"Protein A does not induce allosteric structural changes in an IgG1 antibody during binding","volume":"110","author":"Rincon Pabon","year":"2021","journal-title":"J Pharm Sci"},{"issue":"13","key":"10.1016\/j.xphs.2024.05.008_bib0040","doi-asserted-by":"crossref","first-page":"8008","DOI":"10.1021\/acs.analchem.9b01325","article-title":"Reliable identification of significant differences in differential hydrogen exchange-mass spectrometry measurements using a hybrid significance testing approach","volume":"91","author":"Hageman","year":"2019","journal-title":"Anal Chem"},{"issue":"7","key":"10.1016\/j.xphs.2024.05.008_bib0041","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1021\/bc400217g","article-title":"A Potent Anti-CD70 antibody\u2013drug conjugate combining a dimeric pyrrolobenzodiazepine drug with site-specific conjugation technology","volume":"24","author":"Jeffrey","year":"2013","journal-title":"Bioconjug Chem"},{"issue":"3","key":"10.1016\/j.xphs.2024.05.008_bib0042","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1021\/bc7004329","article-title":"Contribution of linker stability to the activities of anticancer immunoconjugates","volume":"19","author":"Alley","year":"2008","journal-title":"Bioconjug Chem"},{"issue":"4","key":"10.1016\/j.xphs.2024.05.008_bib0043","doi-asserted-by":"crossref","DOI":"10.3390\/antib12040068","article-title":"Atypical asparagine deamidation of NW motif significantly attenuates the biological activities of an antibody drug conjugate","volume":"12","author":"Cao","year":"2023","journal-title":"Antibodies"},{"issue":"4","key":"10.1016\/j.xphs.2024.05.008_bib0044","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/jps.21104","article-title":"Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies","volume":"97","author":"Ionescu","year":"2008","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2024.05.008_bib0045","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.bbrc.2007.02.042","article-title":"A broad range of Fab stabilities within a host of therapeutic IgGs","volume":"355","author":"Garber","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.xphs.2024.05.008_bib0046","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jchromb.2016.07.023","article-title":"Antibody-drug conjugate characterization by chromatographic and electrophoretic techniques","volume":"1032","author":"Chen","year":"2016","journal-title":"J Chromatogr B"},{"issue":"4","key":"10.1016\/j.xphs.2024.05.008_bib0047","doi-asserted-by":"crossref","DOI":"10.3390\/antib6040020","article-title":"Pyrrolobenzodiazepine antibody-drug conjugates designed for stable thiol conjugation","volume":"6","author":"Christie","year":"2017","journal-title":"Antibodies"},{"issue":"4","key":"10.1016\/j.xphs.2024.05.008_bib0048","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1021\/bc400439x","article-title":"Auristatin antibody drug conjugate physical instability and the role of drug payload","volume":"25","author":"Adem","year":"2014","journal-title":"Bioconjug Chem"},{"issue":"1-2","key":"10.1016\/j.xphs.2024.05.008_bib0049","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijpharm.2018.08.043","article-title":"Protein aggregation \u2013 mechanisms, detection, and control","volume":"550","author":"Wang","year":"2018","journal-title":"Int J Pharm"},{"issue":"7","key":"10.1016\/j.xphs.2024.05.008_bib0050","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1021\/acs.molpharmaceut.8b00177","article-title":"Impact of payload hydrophobicity on the stability of antibody\u2013drug conjugates","volume":"15","author":"Buecheler","year":"2018","journal-title":"Mol Pharm"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924001801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924001801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T06:50:37Z","timestamp":1724741437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354924001801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0022354924001801"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2024.05.008","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the Effects of Site-Specific Light Chain Conjugation on Antibody Structure Using Hydrogen Exchange-Mass Spectrometry (HX-MS)","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2024.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}